Furadantin in Urinary-Tract Infections

Publisher Website
Google Scholar
Abstract
ANUMBER of infections encountered in urologic practice, primarily those due to Proteus vulgaris and Pseudomonas aeruginosa, are resistant to many antibiotic and chemotherapeutic agents. Furadantin,** a more recent chemotherapeutic agent, has shown considerable promise as a urinary antiseptic.1 2 3 4 5 6 7 8 9 10 According to available reports, this drug is effective in infections due to both gram-positive and grami-negative organisms, including P. vulgaris. However, Furadantin has not been sufficiently evaluated to permit definitive conclusions regarding its antibacterial spectrum, long-range clinical effectiveness and patient tolerance. The present paper concerns a further study of the drug as a urinary antiseptic. Findings are summarized and correlated . . .

This publication has 5 references indexed in Scilit: